Simparica Trio

Authorised

This medicine is authorised for use in the European Union

sarolaner / moxidectin / pyrantel embonate

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Simparica Trio : EPAR - Medicine overview

Product information

Simparica Trio : EPAR - Product information

Simparica Trio : EPAR - All authorised presentations

Product details

• Name of medicine:
  Simparica Trio
• Active substance:
  • moxidectin
  • sarolaner
  • pyrantel embonate
• International non-proprietary name (INN) or common name:
  • sarolaner
  • moxidectin
  • pyrantel embonate

Pharmacotherapeutic group

Antiparasitics

Authorisation details

• EMA product number:
  EMEA/V/C/004846

Assessment history

Changes since initial authorisation of medicine

Simparica Trio : EPAR - Procedural steps taken and scientific information after authorisation

CVMP post-authorisation summary of positive opinion for Simparica Trio

Adopted Reference Number: EMADOC-1700519818-1896425

CVMP post-authorisation summary of opinion for Simparica Trio

Adopted Reference Number: EMADOC-1700519818-1721693

CVMP post-authorisation summary of positive opinion for Simparica Trio

Adopted Reference Number: EMA/CVMP/904196/2022

Initial marketing authorisation documents

Simparica Trio : EPAR - Public assessment report

Adopted

CVMP summary of positive opinion for Simparica Trio

Adopted Reference Number: EMA/CVMP/364931/2019